SuperSonic Imagine Raises €34.5 Million to Support Development and Global Expansion

handshake.jpg

SuperSonic Imagine, an innovative ultrasound medical imaging company, has announced the completion of a €34.5 million Series C financing, to develop additional clinical applications and commercial expansion at global level.The Series C financing round was led by Mérieux Développement, followed by Canon, Inc. and InnoBio to bring a total of €15.5 million from new investors.

 

The funds will be used to accelerate development of SuperSonic Imagine’s unique technology and to finance the worldwide commercialisation of the Aixplorer® MultiWaveTM Ultrasound System. After an initial focus on breast imaging, the company will now expand the dedicated clinical applications of Aixplorer to include: liver, thyroid, abdominal, musculoskeletal, gynecological and prostate imaging. Jacques Souquet, founder and CEO of SuperSonic Imagine commented, “We originally set out to raise €25 million and it was a great satisfaction to see this round oversubscribed to bring a total amount of €34.5 million. These funds transform the financial situation of SuperSonic Imagine and give us the means to accelerate our R&D and to penetrate key commercial markets.”“We are also pleased with the recent partnership with Hologic Inc. and the launch of the new MultiWave platform.” said François Valencony, Managing Director of Mérieux Développement.

 

SuperSonic Imagine’s Aixplorer® ultrasound system is the only product on the market that uses revolutionary MultiWaveTM Technology to image not one, but two waves to better characterise tissue. One ultrasound wave ensures impeccable image quality and the other, a shear wave, displays in real- time, local tissue elasticity in kilopascals*. Aixplorer is the only system available that can, in real-time, generate, capture and compute shear wave velocity resulting in the bi-dimensional display of true tissue elasticity on a color-coded map. And the assessment of tissue stiffness is essential for physicians as it brings more information about a lesion.

 

Dr. Toshiaki Ikoma, Executive Vice President & CTO, Canon Inc. added, “SuperSonic Imagine’s UltraFast Imaging is a unique and cutting edge technology with a great potential to expand into various functionalities. We are very pleased with this investment as a symbol of our future collaboration.”

Published on : Tue, 7 Dec 2010


Print as PDF
SuperSonic Imagine, an innovative ultrasound medical imaging company, has announced the completion of a €34.5 million Series C financing, to develop additi

No comment


Please login to leave a comment...

Highlighted Products